Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Apolipoprotein and inflammatory biomarker changes following marked triglyceride reduction with the GalNAc-conjugated APOC3 siRNA RBD5044

RBD5044, a GalNAc-conjugated small interfering RNA (siRNA) targeting APOC3, demonstrated robust lipid-lowering efficacy in a Phase I clinical trial. It achieved a 70% reduction in plasma triglyceride (TG) levels, with over 50% reduction maintained at six months. Elevated apoC-III concentrations have previously be...

S. Nilsson, S. Ueckert, A. Gabrielsen et al. · 0 citations
Open access Oct 2026

Proteomic signatures reveal why not all apolipoprotein B-containing lipoproteins are equal in atherosclerosis

All apolipoprotein B (apoB)-containing lipoproteins are causal risk factors for coronary artery disease (CAD). However, triglyceride-rich lipoproteins (TRL) and lipoprotein(a) [Lp(a)] exhibit greater per-particle atherogenicity than low-density lipoprotein (LDL) through mechanisms that remain incompletely underst...

J. Morze, E. Bjornson, Michael Y. Mi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.